Thyroid News

The FDA has rejected a new drug application for an agent to treat adults with hypoparathyroidism due to concerns with manufacturing control strategy, according to an industry press release.

Adults with type 2 diabetes and a high thyroid-stimulating hormone level are more likely to develop diabetic retinopathy, and low time in range further increases the risk for diabetic retinopathy, according to study data.

Last week, April 20th, was my 64th birthday.

In the last post, I told the story of two brothers and made some observations about identical twins. It just so happened that the stories on identical twins kept coming.

The FDA approved expanded indication language to allow the use of teprotumumab for the treatment of thyroid eye disease for any level of activity or duration, according to a press release.

Genetic testing can be used to confirm a congenital hypothyroidism diagnosis for children, according to findings published in the European Thyroid Journal.

Parathyroidectomy had no significant impact on long-term kidney function among older adults with primary hyperparathyroidism, but if done early, it could preserve function in those aged younger than 60, according to researchers.

Teprotumumab is associated with a greater reduction in proptosis than placebo at 24 weeks among adults with chronic thyroid eye disease and a low clinical activity score, according to topline results.

Older adults with a history of hypothyroidism who were hospitalized with COVID-19 had a similar risk for severe outcomes and mortality compared with those without hypothyroidism, according to study data.

Patients with juvenile idiopathic arthritis who demonstrate female sex, antinuclear antibody positivity and a positive family history have a higher risk for autoimmune thyroid disease, according to data published in Pediatric Rheumatology.